CRIP1
Cysteine-rich protein 1
Also known as: CRIP, CRIP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P50238
- Gene
- CRIP1
- Ensembl
- ENSG00000213145
- Chromosome
- 14
- Canonical length
- 77 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles,Plasma membrane,Centrosome,Cytosol
OverviewNCBI Gene
Cysteine-rich intestinal protein (CRIP) belongs to the LIM/double zinc finger protein family, members of which include cysteine- and glycine-rich protein-1 (CSRP1; MIM 123876), rhombotin-1 (RBTN1; MIM 186921), rhombotin-2 (RBTN2; MIM 180385), and rhombotin-3 (RBTN3; MIM 180386). CRIP may be involved in intestinal zinc transport (Hempe and Cousins, 1991 [PubMed 1946385]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
77 residues, UniProt reviewed canonical sequence.
>P50238|CRIP1
1 MPKCPKCNKE VYFAERVTSL GKDWHRPCLK CEKCGKTLTS GGHAEHEGKP YCNHPCYAAM
61 FGPKGFGRGG AESHTFKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRIP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 549 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 549 nTPM
- small intestine: 294 nTPM
- epididymis: 195 nTPM
- lung: 193 nTPM
- skin: 173 nTPM
- heart muscle: 154 nTPM
Single-cell type
- enterocytes: 4,888 nCPM
- epididymal efferent duct ciliated cells: 2,456 nCPM
- endometrial ciliated cells: 1,717 nCPM
- epididymal principal cells: 1,640 nCPM
- vascular smooth muscle cells: 1,104 nCPM
- cdc: 686 nCPM
Immune cell
- memory B-cell: 700 nTPM
- T-reg: 697 nTPM
- total PBMC: 466 nTPM
- myeloid DC: 444 nTPM
- memory CD4 T-cell: 443 nTPM
- naive B-cell: 387 nTPM
Brain region
- midbrain: 28 nTPM
- medulla oblongata: 24 nTPM
- spinal cord: 18 nTPM
- pons: 13 nTPM
- thalamus: 11 nTPM
- choroid plexus: 8.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.73
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to antibiotic
- cellular response to UV-B
- heart development
- immune response
- intrinsic apoptotic signaling pathway in response to DNA damage
- prostate gland stromal morphogenesis
- regulation of gene expression
- response to zinc ion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRIP1 as an antibody target. Whether an autoantibody or antibody against CRIP1 could matter depends on whether native CRIP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRIP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CRIP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...